Serological Investigation of the Collagen Degradation Profile of Patients with Chronic Obstructive Pulmonary Disease or Idiopathic Pulmonary Fibrosis

Show other versions (1)

Bibliographic Details
Main Authors:	Diana J. Leeming, Jannie M. Sand, Mette J. Nielsen, Federica Genovese, Fernando J. Martinez, Cory M. Hogaboam, MeiLan K Han, Lloyd B. Klickstein, Morten A. Karsdal
Format:	Article
Language:	English
Published:	SAGE Publishing 2012-09-01
Series:	Biomarker Insights
Online Access:	http://la-press.com/serological-investigation-of-the-collagen-degradation-profile-of-patie-a3336

Similar Items

Serological Investigation of the Collagen Degradation Profile of Patients with Chronic Obstructive Pulmonary Disease or Idiopathic Pulmonary Fibrosis
by: Diana J. Leeming, et al.
Published: (2012-01-01)

Turnover of type I and III collagen predicts progression of idiopathic pulmonary fibrosis
by: H. Jessen, et al.
Published: (2021-07-01)

Heterogeneity in Fibroblast Proliferation and Survival in Idiopathic Pulmonary Fibrosis
by: David Michael Habiel, et al.
Published: (2014-01-01)

A serological marker of the N-terminal neoepitope generated during LOXL2 maturation is elevated in patients with cancer or idiopathic pulmonary fibrosis
by: D.J. Leeming, et al.
Published: (2019-03-01)

Biomarkers of collagen synthesis predict progression in the PROFILE idiopathic pulmonary fibrosis cohort
by: Louise A. Organ, et al.
Published: (2019-07-01)

MMP mediated degradation of type IV collagen alpha 1 and alpha 3 chains reflects basement membrane remodeling in experimental and clinical fibrosis--validation of two novel biomarker assays.
by: Jannie Marie Sand, et al.
Published: (2013-01-01)

Development of a Novel Enzyme-Linked Immunosorbent Assay Targeting a Neo-Epitope Generated by Cathepsin-Mediated Turnover of Type III Collagen and Its Application in Chronic Obstructive Pulmonary Disease.
by: Daniel Guldager Kring Rasmussen, et al.
Published: (2017-01-01)

Lysyl oxidases regulate fibrillar collagen remodelling in idiopathic pulmonary fibrosis
by: Gavin Tjin, et al.
Published: (2017-11-01)

Possible Serological Markers to Predict Mortality in Acute Exacerbation of Idiopathic Pulmonary Fibrosis
by: Yoshimasa Hachisu, et al.
Published: (2019-05-01)

Idiopathic pulmonary fibrosis
by: Noble Paul W, et al.
Published: (2008-03-01)

Idiopathic Pulmonary Fibrosis
Published: (2022)

A Serological Biomarker of Versican Degradation is Associated with Mortality Following Acute Exacerbations of Idiopathic Interstitial Pneumonia
by: Jannie M. B. Sand, et al.
Published: (2018-05-01)

Phosphodiesterase inhibition mediates matrix metalloproteinase activity and the level of collagen degradation fragments in a liver fibrosis <it>ex vivo</it> rat model
by: Veidal Sanne Skovgård, et al.
Published: (2012-12-01)

Cough in idiopathic pulmonary fibrosis
by: Mirjam J.G. van Manen, et al.
Published: (2016-09-01)

Molecular Serum Markers of Liver Fibrosis
by: Tianhui Liu, et al.
Published: (2012-01-01)

Molecular Serum Markers of Liver Fibrosis
by: Diana J. Leeming, et al.
Published: (2012-07-01)

A micro RNA processing defect in rapidly progressing idiopathic pulmonary fibrosis.
by: Sameer R Oak, et al.
Published: (2011-01-01)

Exacerbation of idiopathic pulmonary fibrosis
by: S. N. Avdeev, et al.
Published: (2020-03-01)

Epidemiology of idiopathic pulmonary fibrosis
by: Ley B, et al.
Published: (2013-11-01)

The pathogenesis of idiopathic pulmonary fibrosis
by: William R. Coward, et al.
Published: (2010-12-01)

IPF - Idiopathic Pulmonary Fibrosis
Published: (2019-06-01)

Autophagy in idiopathic pulmonary fibrosis.
by: Avignat S Patel, et al.
Published: (2012-01-01)

Smoking and Idiopathic Pulmonary Fibrosis
by: Chad K. Oh, et al.
Published: (2012-01-01)

The pathogenesis of idiopathic pulmonary fibrosis
by: Fahim, Ahmed
Published: (2011)

DNA-PKcs modulates progenitor cell proliferation and fibroblast senescence in idiopathic pulmonary fibrosis
by: David M. Habiel, et al.
Published: (2019-08-01)

Failure of noninvasive prediction of pulmonary hypertension in patients with idiopathic pulmonary fibrosis
by: F. Salajka, et al.
Published: (2015-12-01)

Telomere Abnormalities in the Pathobiology of Idiopathic Pulmonary Fibrosis
by: Hasancan Bilgili, et al.
Published: (2019-08-01)

Hospitalizations in patients with idiopathic pulmonary fibrosis
by: Hyun J. Kim, et al.
Published: (2021-09-01)

Value of pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis
by: Nizar Rifaat, et al.
Published: (2014-10-01)

Bosentan for pulmonary hypertension secondary to idiopathic pulmonary fibrosis
by: Naomi Onda, et al.
Published: (2015-01-01)

Markers of Collagen Remodeling Detect Clinically Significant Fibrosis in Chronic Hepatitis C Patients.
by: Mette J Nielsen, et al.
Published: (2015-01-01)

Predictors of osteopenic syndrome in idiopathic pulmonary fibrosis
by: E A Kochetkova, et al.
Published: (2013-03-01)

Macrophage-Derived Biomarkers of Idiopathic Pulmonary Fibrosis
by: E. Bargagli, et al.
Published: (2011-01-01)

Prognosis of combined pulmonary fibrosis and emphysema: comparison with idiopathic pulmonary fibrosis alone
by: Chun-guo Jiang, et al.
Published: (2019-11-01)

Differential diagnosis of idiopathic pulmonary fibrosis
by: E. I. Shmelev, et al.
Published: (2020-03-01)

Metabolic Dysregulation in Idiopathic Pulmonary Fibrosis
by: Elena Bargagli, et al.
Published: (2020-08-01)

Fibroblast Senescence in Idiopathic Pulmonary Fibrosis
by: Yifan Lin, et al.
Published: (2020-11-01)

Idiopathic Pulmonary Fibrosis: Treatment and Prognosis
by: Hajime Fujimoto, et al.
Published: (2016-12-01)

Role of Osteopontin in Idiopathic Pulmonary Fibrosis.
Published: (2005-09-01)

Nintedanib in the treatment of idiopathic pulmonary fibrosis
by: Mariano E. Mazzei, et al.
Published: (2015-06-01)

Cannot write session to /tmp/vufind_sessions/sess_54n3lqmofsanae3vthdiasqt6q